Zika virus Ultra-Cheap, Sensitive DNA Nanoswitch Tech Developed for SARS-CoV-2 Detection Premium The method uses standard lab equipment and the nanoswitches can be easily reconfigured and made in large batches at a cost of about $0.01 per reaction. Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease Premium Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments. Grifols ART System Nabs FDA Approval The system is approved for use with the Procleix Ultrio Elite Assay, the Procleix WNV Assay, Procleix Zika Virus Assay, and the Procelix Babesia Assay. Broad Institute Researchers Develop Viral Detection Platform Based on Microfluidics, CRISPR Tech The platform can detect a single virus in more than 1,000 samples at a time or more than 160 viruses, including SARS-CoV-2, in a small number of samples. Ontera Developing Single-Pore Sensor for Sepsis, TB, and Zika Diagnostic Testing Premium The company has developed a proof-of-concept single-pore sensor that it anticipates integrating into a prototype testing platform this year. Dec 16, 2019 Roche Applies CE Mark to Zika Screening Test Oct 31, 2019 Sherlock Biosciences Aims to Create Dx Tool for 'Where Testing Should be Done, But Isn't' Premium Oct 10, 2019 Broad Institute Researchers Develop CRISPR-Based Diagnostic, Antiviral Platform Premium Aug 22, 2019 Unreported Zika Outbreak in Cuba Uncovered With Genomics, Travel Surveillance Jun 18, 2019 Ontera Lands $983K IARPA Contract for Zika Genotyping Test Mar 26, 2019 CDC, Group K Diagnostics Collaborate to Design, Evaluate Zika POC Test Mar 21, 2019 Broad, Wyss Institute Researchers Launch CRISPR Dx Firm Sherlock Biosciences Mar 7, 2019 Co-Diagnostics Gets CE-IVD Mark for Multiplex Zika, Dengue, Chikungunya Test Nov 14, 2018 New Mosquito Genome Expected to Serve as Infectious Disease Resource Nov 5, 2018 Protein Profiles Could ID Zika-Infected Pregnant Women at High Risk of Abnormal Births Nov 1, 2018 RNA Virus Reservoir, Vector Predictions From Genome Data May Help Prevent Disease Outbreaks Oct 26, 2018 New Zika Genomes From African, Asian Lineages Document Virus' Population Diversity Oct 18, 2018 Co-Diagnostics Receives CE-IVD Marking for Zika Test Aug 14, 2018 Grifols Gets FDA Clearance for Procleix Zika Virus Assay Jul 6, 2018 FDA Revises Zika Virus Screening Guidance, Recommends Pooled Testing of Blood May 24, 2018 Zika Virus Genomes Elucidate Disease Spread in Central America, Mexico May 14, 2018 FDA Approves Additional Claim for Roche Zika Test May 10, 2018 Zika Screening of Individual Blood Donations Costs $5M for Every Positive Result, Study Shows May 9, 2018 Mammoth Biosciences Developing CRISPR-Based Disease Detection for At-Home, Hospital Use Premium Apr 26, 2018 Broad Researchers Develop Protocol to Use CRISPR-Based Diagnostic Tool for Zika Testing Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.